Filtros de búsqueda

Lista de obras de Brent A Hanks

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

Comparison of the functional differences for the homologous residues within the carboxy phosphate and carbamate domains of carbamoyl phosphate synthetase.

artículo científico publicado en 1996

Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy

artículo científico publicado en 2014

Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy

artículo científico publicado en 2016

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

artículo científico publicado en 2017

Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma

artículo científico publicado en 2014

Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.

artículo científico

Ipilimumab and Radiation in Patients with High Risk Resected or Regionally Advanced Melanoma

artículo científico publicado en 2020

Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.

artículo científico publicado en 2016

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy

artículo científico publicado en 2015

Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.

artículo científico publicado en 2018

Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis.

artículo científico publicado en 2015

Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo.

artículo científico publicado en 2005

Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion

scientific article published on 10 December 2019

Role of conserved residues within the carboxy phosphate domain of carbamoyl phosphate synthetase

artículo científico publicado en 1996

Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab

artículo científico publicado en 2016

Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGF-β Inhibitor Sequencing in Melanoma

artículo científico publicado en 2018

TUMOR MUTATIONAL BURDEN AS A PREDICTOR OF IMMUNOTHERAPY RESPONSE: IS MORE ALWAYS BETTER?

artículo científico publicado en 2020

The State of Melanoma: Emergent Challenges and Opportunities

scientific article published on 07 January 2021

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

scientific article published in 2022

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda